Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2019
Price : $35 *
At a glance
- Drugs Isoniazid (Primary) ; Rifapentine (Primary) ; Tenofovir alafenamide (Primary) ; Pyridoxine
- Indications Hepatitis B; HIV infections; HIV-1 infections; Tuberculosis
- Focus Pharmacokinetics
- Acronyms YODA
- 03 Apr 2019 Planned number of patients changed from 30 to 75.
- 13 Jun 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 4 Jun 2018 to 12 Jun 2018.
- 29 May 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 31 May 2018 to 4 Jun 2018.